Avior Wealth Management’s Humacyte HUMA Stock Holding History

Avior Wealth Management’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,000	Closed	-$5.05K	–	1466
2024 Q4	$5.05K	Hold	1,000	–	–	﹤0.01%	1850
2024 Q3	$5.44K	Hold	1,000	–	–	﹤0.01%	1753
2024 Q2	$4.8K	Sell	1,000 -12	-1%	-$62	﹤0.01%	1735
2024 Q1	$3.15K	Buy	1,012 +12	+1%	+$40	﹤0.01%	2196
2023 Q4	$2.84K	Hold	1,000	–	–	﹤0.01%	1265
2023 Q3	$2.93K	Hold	1,000	–	–	﹤0.01%	1337
2023 Q2	$2.86K	Hold	1,000	–	–	﹤0.01%	1312
2023 Q1	$3.09K	Hold	1,000	–	–	﹤0.01%	1334
2022 Q4	$2.11K	Hold	1,000	–	–	﹤0.01%	1047
2022 Q3	$3K	Hold	1,000	–	–	﹤0.01%	986
2022 Q2	$3K	Hold	1,000	–	–	﹤0.01%	912
2022 Q1	$7K	Hold	1,000	–	–	﹤0.01%	876
2021 Q4	$7K	Hold	1,000	–	–	﹤0.01%	846
2021 Q3	$11K	Hold	1,000	–	–	﹤0.01%	755
2021 Q2	$10K	Hold	1,000	–	–	﹤0.01%	747
2021 Q1	$10K	Buy	+1,000	New	+$10.9K	﹤0.01%	759

Other funds holding HUMA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Avior Wealth Management's HUMA Position: Q1 2025 in Review

Avior Wealth Management sold out of Humacyte (HUMA) in Q1 2025, closing a stake of 1,000 shares — an estimated $5.05K sold.

Avior Wealth Management first reported a position in HUMA in Q1 2021 and held it in 16 quarters. The position peaked at $11K in Q3 2021. 168 funds tracked by Wall St. Rank hold HUMA as of Q1 2025.

Avior Wealth Management reported no remaining Humacyte position as of Q1 2025 after selling out during the quarter.
Avior Wealth Management sold 1,000 Humacyte shares in Q1 2025, an estimated $5.05K.
Avior Wealth Management first reported a position in Humacyte in Q1 2021 and held it in 16 quarters.
Avior Wealth Management's Humacyte position peaked at $11K in Q3 2021.
168 funds tracked by Wall St. Rank held Humacyte as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.